Brigham Buhler08 March 2025

Ex-Pharma Rep: Why American Healthcare Is So Broken - Brigham Buhler - #912

0Frameworks

8Insights

Insights & moments

The myth-busts, hot takes, explainers, and tools worth keeping.

Myth Buster· 3

Myth Buster03:30

Insurance Companies Profit from Your Illness

Contrary to the belief that insurance companies exist to cover your care, they are structured to profit from it. Pharmacy Benefit Managers (PBMs), owned by insurers, negotiate drug prices not to lower costs, but to create rebates and kickbacks, incentivizing higher drug prices and more prescriptions.

Insurance companies made 4x more revenue than Big Pharma last year, primarily from prescription drugs via PBMs.
PBMs were created to lower drug costs but were captured by insurers to inflate prices and collect rebates.
Insurers pass the inflated costs to employers, hiding the true burden from patients.
The system incentivizes keeping patients on drugs, not curing them.

“the big five insurance companies made four times the revenue of the biggest five pharmaceutical companies last year”
guest · 03:30

“they negotiated rebates on almost every major pharmaceutical product and if you want to be on United healthc Care's plan you got to pay to…”
guest · 09:00

#insurance#PBM#prescription drugs#healthcare costs

Myth Buster18:30

Compounding Pharmacies Are Not Dangerous

Compounding pharmacies are often vilified as unsafe, but this is a narrative pushed by Big Pharma to eliminate competition. In reality, they produce FDA-approved ingredient-based medications with rigorous third-party testing, often providing safer and far cheaper alternatives to branded drugs.

Compounding pharmacies use FDA-approved ingredients and undergo independent third-party verification.
Big Pharma attacks compounding pharmacies to protect their own high-priced, patented drugs.
The FDA has failed to inspect thousands of Big Pharma facilities, while scrutinizing smaller compounding operations.
Compounding pharmacies provided life-saving HIV treatments at $12/month vs. $122,000/month from Big Pharma.

“every single product we make is FDA improved ingredients that come from the same exact suppliers this big Pharma”
guest · 19:30

“there are over 5,000 big pharmaceutical manufacturing facilities that the FDA has not inspected in five or more [__] years”
guest · 20:00

#compounding pharmacy#Big Pharma#FDA#drug safety

Myth Buster24:30

SSRIs Are Mostly Placebo

Antidepressants (SSRIs) are widely prescribed, but their efficacy is largely due to the placebo effect. According to meta-analyses of Big Pharma's own studies, 85% of their effectiveness is placebo, and they carry serious risks like increased suicidal ideation.

85% of SSRI efficacy is attributable to the placebo effect, based on Big Pharma's own studies.
SSRIs have a 50% relapse rate and can cause increased suicidal thoughts and violent behavior.
On a 52-point depression scale, SSRIs differ from placebo by only 1-2 points.
Lifestyle factors like diet and exercise are more effective and safer.

“85% of the efficacy of an SSRI was related to Placebo”
guest · 26:00

“on a 52 point scale a depression scale it different differentiates from Placebo by 1 to two points”
guest · 26:30

#antidepressants#SSRI#mental health#placebo

Explainer· 3

Explainer00:00

The Root Cause of America's Broken Healthcare System

The U.S. healthcare system is fundamentally broken not by accident, but by design. Its core incentive structure prioritizes monetizing chronic disease over curing it. This systemic issue is driven by corporate capture across food, pharmaceuticals, insurance, and regulatory bodies, all aligned to profit from illness rather than promote health.

The primary driver is a profit-first model that incentivizes chronic disease management, not cures.
Corporate capture affects every level: food supply, insurance, pharmaceuticals, and regulatory agencies like the FDA and CDC.
The system is rigged to benefit corporations at the expense of public health and financial well-being.
Healthcare costs are the number one cause of bankruptcy in the U.S.

“the number one cause of bankruptcy in America is healthcare costs”
host · 00:00

“our entire incentive systems in this country are based off monetizing and capitalizing off chronic disease”
guest · 01:30

#healthcare system#corporate capture#chronic disease#profit incentives

Explainer00:30

Why the U.S. Food Supply Has 10,000 Ingredients

The U.S. allows approximately 10,000 approved food ingredients, compared to around 700 in Europe. This vast difference stems from lax regulation and corporate influence, leading to widespread contamination and health risks in the American diet.

The U.S. has about 10,000 approved food ingredients, while Europe has around 700.
Same corporations produce different ingredient sets for the U.S. and Canada, indicating a regulatory double standard.
This permissive environment contributes to poor health outcomes.
Food contaminants are a root cause of chronic disease.

“in the United States in the 80s we had 700 approved ingredients in our food now we have 10,000 in Europe it's still close to…”
guest · 00:30

#food safety#regulation#nutrition#public health

Explainer72:30

How Medical Devices Get Approved Without Safety Studies

92% of products used in operating rooms, including implants and surgical tools, never underwent human safety studies. They are approved through the FDA's 510(k) process, which allows them to 'daisy-chain' approval from older, similar devices, creating significant patient risk.

The 510(k) approval process allows devices to be approved based on similarity to older devices, not new safety data.
This means a device approved in 1982 can be the basis for a modern AI-powered device with no new human testing.
Examples include devices that caused organ damage and surgical equipment that failed during critical procedures.
Patients are often unaware of the risks associated with these untested devices.

“92% of the products in the operating room never had a human safety study”
guest · 72:30

“the study was done in 1982 and now we're 30 Generations away with a product”
guest · 73:30

#FDA#medical devices#510k#patient safety

Story· 1

Story11:00

How Insurance Companies Profited from the Opioid Crisis

During the opioid epidemic, insurance companies quietly collected 30% of the revenue generated from opioid abuse through negotiated rebates. Despite their central role, they faced no legal consequences, lawsuits, or public scrutiny, allowing them to profit while others were blamed.

Insurance companies negotiated rebates on opioid drugs, creating a direct profit incentive.
An estimated 30% of opioid-related revenue went to insurers.
Despite this, insurers were never indicted, sued, or questioned for their role.
They actively obstructed safer, non-addictive alternatives to protect their profits.

“30% of the money and revenue generated from opioid abuse in this country went to the big insurance companies”
guest · 11:00

“they actively obstructed the ability to products like ibigan in the United States”
guest · 13:30

#opioid crisis#insurance#corporate profit#public health

Takeaway· 1

Takeaway92:30

Take Control: Use Cash-Pay Clinics for Better Care

To avoid the broken insurance model, patients should seek cash-pay clinics that offer preventative and proactive care. These clinics are not bound by insurance restrictions and can provide comprehensive testing and personalized treatment plans.

Insurance-based plans restrict access to preventative care and limit treatment options.
Cash-pay clinics offer more comprehensive services like blood panels, DEXA scans, and VO2 max testing.
Taking financial and personal accountability for your health is crucial.
Avoid letting insurance companies control your health data and decisions.

“find a cash pay clinic in your area because I don't I'm I don't know of a lot of insurance-based plans that will allow you…”
guest · 92:30

#patient advocacy#preventative care#cash pay#health sovereignty